We are delighted to welcome Dr Kylie de Boer PhD GAICD to the Mito Foundation Board of Directors. Her insight and experience will significantly strengthen our work for the mito community.
Kylie’s appointment reinforces our strategic focus and determination to accelerate progress towards effective treatments and cures for mitochondrial disease.
Kylie brings a wealth of expertise across healthcare, technology and innovation. She has led organisations through international expansion and transformational change.
Her background in health, genetics and emerging technologies, enhances the Board’s oversight as we continue to advance research and innovation.
Please join us in welcoming Kylie as she begins her Board tenure and helps shape the Foundation’s next chapter.
We would also like to acknowledge Lisa Cheng for her contributions as she steps down from the Board. Thank you, Lisa.
Read more about the incredible people at Mito Foundation at mito.org.au/our-people/.
